Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

Overview of attention for article published in Journal of Hematology & Oncology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

Readers on

mendeley: 76 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 70,152 followers.

From https://t.co/IqABPtVMUW 2/ https://t.co/vcPkd1X7vA

21 Aug 2023

Reply Repost Favourite

A prediction from this is we should see Anti-CD24 Antibodies in some people as well as possibly other antibodies associated with Nitric Oxide pathways driving over active immune state ala: https://t.co/vEw7gswxGJ

29 Jul 2023

Reply Repost Favourite

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology https://t.co/eBoSlh3hVw https://t.co/dGS0slcTeD

07 Aug 2022

Reply Repost Favourite

@Kto72102356 Il y en a plusieurs en développement (malheureusement leur phase 3 avance lentement depuis l'été 2021) : ExoCD24 et FcCD24 sont un exemple prometteur pour traiter les formes sévères en ciblant la réponse inflammatoire (donc "variant proof") :

02 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.